In the current study, we identified BCR-related radiomics features as well as significantly altered metabolite levels, especially methionine, in patients with PCa receiving CIRT, and revealed the potential molecular significance of these radiomics features in a radiometabolomics manner, using a combination of radiomics and metabolomics. The gene discussed is BCR; the disease is posterior cortical atrophy.